LifeStance Health Group (LifeStance Health Group) EV-to-EBIT : -16.05 (As of May. 06, 2024)

LifeStance Health Group EV-to-EBIT Chart

LifeStance Health Group Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial												-10.46	-17.76	-23.22	-15.14	-18.31

Competitive Comparison of LifeStance Health Group's EV-to-EBIT

For the Medical Care Facilities subindustry, LifeStance Health Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LifeStance Health Group's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, LifeStance Health Group's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where LifeStance Health Group's EV-to-EBIT falls into.

LifeStance Health Group EV-to-EBIT Calculation

LifeStance Health Group's EV-to-EBIT for today is calculated as:

LifeStance Health Group's current Enterprise Value is $2,975 Mil.
LifeStance Health Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-185 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LifeStance Health Group  (NAS:LFST) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

LifeStance Health Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

LifeStance Health Group's Enterprise Value for the quarter that ended in Dec. 2023 was $3,395 Mil.
LifeStance Health Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-185 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LifeStance Health Group EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of LifeStance Health Group's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

LifeStance Health Group (LifeStance Health Group) Business Description